GlassScriptPhysician profile
Larry M Perich
NPI 1891724019
$8,436.14
in general payments reported to CMS, 2019-2025
34 companies · $908 in 2025
The $908 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $2,491 · 2021: $1,381 · 2022: $1,056 · 2023: $544 · 2024: $1,184 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,635.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $2,126.14 | 2020 | |
| Abbvie INC. | $800.94 | 2022-2025 | |
| Allergan, INC. | $735.34 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $684.16 | 2021 | |
| Alcon Vision LLC | $504.20 | 2019-2025 | Clareon, Centurion, Unity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $352.31 | 2019-2021 | |
| Horizon Therapeutics Plc | $351.08 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $338.82 | 2021-2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $274.45 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $213.95 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $209.90 | 2019-2024 | Cequa |
| Ani Pharmaceuticals, INC. | $199.26 | 2023-2024 | Purified Cortrophin Gel |
| Dompe US, INC. | $166.94 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $162.62 | 2022-2024 | Xiidra, Miebo |
| Amgen INC. | $133.46 | 2024-2025 | Tepezza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $130.92 | 2019 | |
| Eyepoint US, INC. | $129.40 | 2024 | |
| Novartis Pharmaceuticals Corporation | $117.79 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $117.68 | 2025 | |
| Astellas Pharma US INC | $113.00 | 2024-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $98.39 | 2024-2025 | Syfovre |
| Oyster Point Pharma, INC. | $83.89 | 2022-2024 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $81.49 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $75.19 | 2023 | Tecnis Iol, Ifs Advanced Femtosec Laser, Veritas Vision System |
| Sight Sciences, INC. | $45.35 | 2021-2024 | Tearcare System |
| Thea Pharma INC. | $36.57 | 2024 | Iyuzeh |
| New World Medical,INC. | $33.26 | 2024-2025 | Kahook Dual Blade, Streamline, Clearpath |
| Harrow Eye, LLC | $24.74 | 2024 | Iheezo |
| Mauna Kea Technologies, INC. | $22.34 | 2025 | |
| Biotissue Holdings INC. | $21.61 | 2025 | |
| Ivantis, INC | $14.60 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.28 | 2019 | |
| Iridex Corporation | $11.19 | 2019 | |
| Eyevance Pharmaceuticals LLC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Perich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.